Dhampur Bio Organics Ltd

Dhampur Bio Organics Limited (DBO) has entered into a Technology Licensing Agreement with Planetary SA, Switzerland, for the exclusive production of Mycoprotein in India. The agreement, effective October 19, 2026, outlines a collaboration model where Planetary provides technology and acts as an off-taker, while DBO will construct and operate the production infrastructure. DBO will pay Planetary a licensing fee of 10% of after-tax revenue quarterly, plus a one-time launch fee for engineering and support. The agreement has an initial term of 10 years, renewable for successive 5-year terms. This partnership aims to establish Mycoprotein commercialization and offtake in India.

Dhampur Bio Organics Ltd has announced promotions for two key senior management personnel, effective October 01, 2026. Mr. Pankaj Agarwal has been elevated from Chief General Manager – Finance and Accounts to Vice President – Finance and Accounts. Concurrently, Mr. Vinamra Agarwal has been promoted from General Manager – Sales & Marketing (Dhampure) to Vice President – Sales & Marketing (Dhampure). Both individuals bring extensive experience to their new roles, with Mr. Agarwal having over 37 years in finance and accounts, and Mr. Vinamra Agarwal possessing over two decades of experience in sales and business development across various sectors. These changes are in line with SEBI (LODR) Regulations, 2015.

Sonitron Limited, a promoter group entity, has purchased 30,000 equity shares of Dhampur Bio Organics Limited through the open market. This transaction represents a 0.045% increase in Sonitron's holding. Following the purchase, Sonitron's total shareholding in Dhampur Bio Organics increased from 17.368% to 17.413%. The total equity share capital of Dhampur Bio Organics remains 6,63,87,590 equity shares.

Sonitron Limited, a promoter entity, has acquired 30,000 equity shares of Dhampur Bio Organics Limited through an open market transaction on September 25, 2026. This purchase represents a 0.045% stake, increasing Sonitron's total holding in Dhampur Bio Organics from 17.368% to 17.413%. The total equity share capital of Dhampur Bio Organics remains 6,63,87,590 equity shares.

Sonitron Limited, a promoter entity, has acquired 10,000 equity shares of Dhampur Bio Organics Limited through an open market transaction on September 22, 2026. This purchase represents a 0.015% stake in the company. Following this acquisition, Sonitron Limited's total shareholding in Dhampur Bio Organics Limited increased from 17.353% to 17.368%. The total equity share capital of Dhampur Bio Organics Limited remains unchanged at 6,63,87,590 equity shares.

Sonitron Limited, a promoter group entity, has acquired 10,000 equity shares of Dhampur Bio Organics Limited through the open market. This transaction represents a 0.015% increase in Sonitron's stake, bringing its total holding to 17.368% (1,15,30,499 shares). The acquisition occurred on September 22, 2026. Dhampur Bio Organics Limited is listed on BSE Limited and the National Stock Exchange of India Limited.

Dhampur Bio Organics Ltd has announced the payment of its final dividend for the Financial Year 2025-26. Shareholders approved a dividend of 15%, equivalent to ₹1.50 per equity share of ₹10 face value, at the Annual General Meeting held on July 24, 2026. The dividend amount has been remitted to shareholders via NACH. The company has also deducted tax at source on dividends exceeding ₹10,000. Shareholders facing non-receipt or discrepancies are advised to contact the Registrar and Share Transfer Agent, Alankit Assignments Limited.

Sonitron Limited, a promoter company, has acquired 25,000 equity shares of Dhampur Bio Organics Limited through open market purchases. This transaction increases Sonitron's shareholding in Dhampur Bio Organics from 17.293% to 17.331%. The acquisition was made on August 5, 2026, and reported under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The total equity share capital of Dhampur Bio Organics remains unchanged at 6,63,87,590 equity shares of Rs. 10 each.

Sonitron Limited has acquired an additional 25,000 equity shares of Dhampur Bio Organics Limited through open market transactions. This acquisition represents approximately 0.038% of the total share capital. Following this transaction, Sonitron Limited's total holding in Dhampur Bio Organics Limited now stands at 1,15,05,499 equity shares, constituting 17.331% of the company's total share capital. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Mr. Lalit Dalal, Vice President - Finance & Accounts of Dhampur Bio Organics Ltd, has resigned from his position effective July 31, 2026. The resignation is to pursue career opportunities outside the organization. The company has provided disclosures as required by SEBI (LODR) Regulations, 2015, including the reason for change and cessation date. Annexure A details the disclosures, and Annexure B contains the resignation letter.